Angelo B Cefalù1, Rossella Spina1, Davide Noto1, Vincenza Valenti1, Valeria Ingrassia1, Antonina Giammanco1, Maria D Panno1, Antonina Ganci1, Carlo M Barbagallo1, Maurizio R Averna2. 1. From the Dipartimento Biomedico di Medicina Interna e Specialistica (DIBIMIS), University of Palermo, Palermo, Italy (A.B.C., R.S., D.N., V.I., A. Giammanco, M.D.P., A. Ganci, C.M.B., M.R.A.); and Molecular Biology Diagnostic Laboratory, Central Laboratory of Advanced Diagnosis and Biomedical Research (CLADIBIOR), AOUP "Paolo Giaccone", Palermo, Italy (A.B.C., R.S., D.N., V.V., V.I., M.R.A.). 2. From the Dipartimento Biomedico di Medicina Interna e Specialistica (DIBIMIS), University of Palermo, Palermo, Italy (A.B.C., R.S., D.N., V.I., A. Giammanco, M.D.P., A. Ganci, C.M.B., M.R.A.); and Molecular Biology Diagnostic Laboratory, Central Laboratory of Advanced Diagnosis and Biomedical Research (CLADIBIOR), AOUP "Paolo Giaccone", Palermo, Italy (A.B.C., R.S., D.N., V.V., V.I., M.R.A.). maurizio.averna@unipa.it abaldassare.cefalu@unipa.it.
Abstract
OBJECTIVE: Cyclic AMP responsive element-binding protein 3-like 3 (CREB3L3) is a novel candidate gene for dominant hypertriglyceridemia. To date, only 4 kindred with dominant hypertriglyceridemia have been found to be carriers of 2 nonsense mutations in CREB3L3 gene (245fs and W46X). We investigated a family in which hypertriglyceridemia displayed an autosomal dominant pattern of inheritance. APPROACH AND RESULTS: The proband was a 49-year-old woman with high plasma triglycerides (≤1300 mg/dL; 14.68 mmol/L). Her father had a history of moderate hypertriglyceridemia, and her 51-year-old brother had triglycerides levels as high as 1600 mg/dL (18.06 mmol/L). To identify the causal mutation in this family, we analyzed the candidate genes of recessive and dominant forms of primary hypertriglyceridemia by direct sequencing. The sequencing of CREB3L3 gene led to the discovery of a novel minute frame shift mutation in exon 3 of CREB3L3 gene, predicted to result in the formation of a truncated protein devoid of function (c.359delG-p.K120fsX20). Heterozygosity for the c.359delG mutation resulted in a severe phenotype occurring later in life in the proband and her brother and a good response to diet and a hypotriglyceridemic treatment. The same mutation was detected in a 13-year-old daughter who to date is normotriglyceridemic. CONCLUSIONS: We have identified a novel pathogenic mutation in CREB3L3 gene in a family with dominant hypertriglyceridemia with a variable pattern of penetrance.
OBJECTIVE:Cyclic AMP responsive element-binding protein 3-like 3 (CREB3L3) is a novel candidate gene for dominant hypertriglyceridemia. To date, only 4 kindred with dominant hypertriglyceridemia have been found to be carriers of 2 nonsense mutations in CREB3L3 gene (245fs and W46X). We investigated a family in which hypertriglyceridemia displayed an autosomal dominant pattern of inheritance. APPROACH AND RESULTS: The proband was a 49-year-old woman with high plasma triglycerides (≤1300 mg/dL; 14.68 mmol/L). Her father had a history of moderate hypertriglyceridemia, and her 51-year-old brother had triglycerides levels as high as 1600 mg/dL (18.06 mmol/L). To identify the causal mutation in this family, we analyzed the candidate genes of recessive and dominant forms of primary hypertriglyceridemia by direct sequencing. The sequencing of CREB3L3 gene led to the discovery of a novel minute frame shift mutation in exon 3 of CREB3L3 gene, predicted to result in the formation of a truncated protein devoid of function (c.359delG-p.K120fsX20). Heterozygosity for the c.359delG mutation resulted in a severe phenotype occurring later in life in the proband and her brother and a good response to diet and a hypotriglyceridemic treatment. The same mutation was detected in a 13-year-old daughter who to date is normotriglyceridemic. CONCLUSIONS: We have identified a novel pathogenic mutation in CREB3L3 gene in a family with dominant hypertriglyceridemia with a variable pattern of penetrance.
Authors: Masami Shimizu-Albergine; Debapriya Basu; Jenny E Kanter; Farah Kramer; Vishal Kothari; Shelley Barnhart; Carissa Thornock; Adam E Mullick; Noemie Clouet-Foraison; Tomas Vaisar; Jay W Heinecke; Robert A Hegele; Ira J Goldberg; Karin E Bornfeldt Journal: J Clin Invest Date: 2021-11-15 Impact factor: 14.808
Authors: George Hindy; Peter Dornbos; Mark D Chaffin; Dajiang J Liu; Minxian Wang; Margaret Sunitha Selvaraj; David Zhang; Joseph Park; Carlos A Aguilar-Salinas; Lucinda Antonacci-Fulton; Diego Ardissino; Donna K Arnett; Stella Aslibekyan; Gil Atzmon; Christie M Ballantyne; Francisco Barajas-Olmos; Nir Barzilai; Lewis C Becker; Lawrence F Bielak; Joshua C Bis; John Blangero; Eric Boerwinkle; Lori L Bonnycastle; Erwin Bottinger; Donald W Bowden; Matthew J Bown; Jennifer A Brody; Jai G Broome; Noël P Burtt; Brian E Cade; Federico Centeno-Cruz; Edmund Chan; Yi-Cheng Chang; Yii-Der I Chen; Ching-Yu Cheng; Won Jung Choi; Rajiv Chowdhury; Cecilia Contreras-Cubas; Emilio J Córdova; Adolfo Correa; L Adrienne Cupples; Joanne E Curran; John Danesh; Paul S de Vries; Ralph A DeFronzo; Harsha Doddapaneni; Ravindranath Duggirala; Susan K Dutcher; Patrick T Ellinor; Leslie S Emery; Jose C Florez; Myriam Fornage; Barry I Freedman; Valentin Fuster; Ma Eugenia Garay-Sevilla; Humberto García-Ortiz; Soren Germer; Richard A Gibbs; Christian Gieger; Benjamin Glaser; Clicerio Gonzalez; Maria Elena Gonzalez-Villalpando; Mariaelisa Graff; Sarah E Graham; Niels Grarup; Leif C Groop; Xiuqing Guo; Namrata Gupta; Sohee Han; Craig L Hanis; Torben Hansen; Jiang He; Nancy L Heard-Costa; Yi-Jen Hung; Mi Yeong Hwang; Marguerite R Irvin; Sergio Islas-Andrade; Gail P Jarvik; Hyun Min Kang; Sharon L R Kardia; Tanika Kelly; Eimear E Kenny; Alyna T Khan; Bong-Jo Kim; Ryan W Kim; Young Jin Kim; Heikki A Koistinen; Charles Kooperberg; Johanna Kuusisto; Soo Heon Kwak; Markku Laakso; Leslie A Lange; Jiwon Lee; Juyoung Lee; Seonwook Lee; Donna M Lehman; Rozenn N Lemaitre; Allan Linneberg; Jianjun Liu; Ruth J F Loos; Steven A Lubitz; Valeriya Lyssenko; Ronald C W Ma; Lisa Warsinger Martin; Angélica Martínez-Hernández; Rasika A Mathias; Stephen T McGarvey; Ruth McPherson; James B Meigs; Thomas Meitinger; Olle Melander; Elvia Mendoza-Caamal; Ginger A Metcalf; Xuenan Mi; Karen L Mohlke; May E Montasser; Jee-Young Moon; Hortensia Moreno-Macías; Alanna C Morrison; Donna M Muzny; Sarah C Nelson; Peter M Nilsson; Jeffrey R O'Connell; Marju Orho-Melander; Lorena Orozco; Colin N A Palmer; Nicholette D Palmer; Cheol Joo Park; Kyong Soo Park; Oluf Pedersen; Juan M Peralta; Patricia A Peyser; Wendy S Post; Michael Preuss; Bruce M Psaty; Qibin Qi; D C Rao; Susan Redline; Alexander P Reiner; Cristina Revilla-Monsalve; Stephen S Rich; Nilesh Samani; Heribert Schunkert; Claudia Schurmann; Daekwan Seo; Jeong-Sun Seo; Xueling Sim; Rob Sladek; Kerrin S Small; Wing Yee So; Adrienne M Stilp; E Shyong Tai; Claudia H T Tam; Kent D Taylor; Yik Ying Teo; Farook Thameem; Brian Tomlinson; Michael Y Tsai; Tiinamaija Tuomi; Jaakko Tuomilehto; Teresa Tusié-Luna; Miriam S Udler; Rob M van Dam; Ramachandran S Vasan; Karine A Viaud Martinez; Fei Fei Wang; Xuzhi Wang; Hugh Watkins; Daniel E Weeks; James G Wilson; Daniel R Witte; Tien-Yin Wong; Lisa R Yanek; Sekar Kathiresan; Daniel J Rader; Jerome I Rotter; Michael Boehnke; Mark I McCarthy; Cristen J Willer; Pradeep Natarajan; Jason A Flannick; Amit V Khera; Gina M Peloso Journal: Am J Hum Genet Date: 2021-12-20 Impact factor: 11.043
Authors: J Humberto Treviño-Villarreal; Justin S Reynolds; Alexander Bartelt; P Kent Langston; Michael R MacArthur; Alessandro Arduini; Valeria Tosti; Nicola Veronese; Beatrice Bertozzi; Lear E Brace; Pedro Mejia; Kaspar Trocha; Gustavo S Kajitani; Alban Longchamp; Eylul Harputlugil; Rose Gathungu; Susan S Bird; Arnold D Bullock; Robert S Figenshau; Gerald L Andriole; Andrew Thompson; Jöerg Heeren; C Keith Ozaki; Bruce S Kristal; Luigi Fontana; James R Mitchell Journal: JCI Insight Date: 2018-11-02